| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.39 |
6e-13 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |